Sep 2026· Strahlentherapie und Onkologie (Print)· 0 citations· 27 references
Medicine
TL;DR
HDR-BT dose escalation after initial EBRT represents a feasible non-operative treatment option for patients unfit for surgery with promising long-term local control and the incidence of late grade 3 rectal bleeding requires careful patient selection.
Abstract
Purpose
For elderly and frail patients with rectal cancer, unfit for radical surgery or extensive chemoradiation schedules, radiotherapy dose escalation by use of high-dose-rate brachytherapy (HDR-BT) may be an alternative organ-preserving approach.
Methods
15 elderly/frail patients (median age, 83 years; ECOG 1‑2: 80%) with histologically confirmed rectal adenocarcinoma (T1-3, N0-1, M0; UICC stage I-IIIB) were treated with definitive radiotherapy consisting of external beam radiation therapy (EBRT) of 30-39 Gy in 10-13 fractions, followed by image-guided endorectal HDR-BT with 12-24 Gy in 2-3 fractions. Acute and late toxicity of combined EBRT and HDR-BT was recorded according to CTCAE v5.0. Initial tumor response (clinical complete response, cCR, near clinical complete response, ncCR, and incomplete response, IR) and long-term disease control were assessed using clinical examination, endoscopy, and magnetic resonance imaging.
Results
Median follow-up was 21 (range, 9-43) months. Six weeks after completion of EBRT + HDR-BT, cCR (n = 6) or ncCR (n = 6) was confirmed in 12/15 patients (80%), 3 patients (20%) had IR. Local regrowth after initial (n)cCR was observed in 4 patients (33%). A total of 4/15 patients (27%) developed distant metastases (2 with IR, 2 with (n)cCR). Most common acute toxicities were mild/moderate proctitis (grade 1-2) in 67%, and mild grade 2 cystitis in 27%. Three patients (20%), of whom two were receiving oral anticoagulation, experienced late grade 3 rectal bleeding, requiring blood transfusion. One patient developed grade 3 rectal ulcer with necrosis treated with rectal amputation.
Conclusions
HDR-BT dose escalation after initial EBRT represents a feasible non-operative treatment option for patients unfit for surgery with promising long-term local control. The incidence of late grade 3 rectal bleeding, especially in patients receiving concomitant oral anticoagulation, requires careful patient selection, and further dose and treatment optimization (as implemented in the upcoming ACO/ARO/AIO-22 trial).
OBJECTIVE
To report long-term outcomes and late toxicity after external beam radiotherapy (EBRT) with single-fraction high-dose-rate brachytherapy boost (HDR-BTB) for localized prostate cancer, examining HDR-BT sequencing and risk stratification.
METHODS AND MATERIALS
We retrospectively analyzed 607 (2012-2023) men t...
M. Choudhury, F. Adeoye, S. Nageshwaran et al.· Brachytherapy· 0 citations
A
BSTRACT
Elderly patients with head and neck squamous cell carcinoma (HNSCC) often cannot tolerate prolonged conventional radiotherapy and are under-represented in trials. As the meta-analysis of chemotherapy in head and neck cancer meta-analysis shows the benefit of concurrent chemotherapy diminishes with a...
M. S. Pranav, G. Vydia, Ramanaiah Kaluvoya· Journal of Radiation and Can...· 0 citations
Findings support this approach for appropriately selected patients in routine clinical care for intermediate- and high-risk prostate cancer, as contemporary real-world evidence remains limited.
Z. El Kouzi, M. Rooney, Adam B. Samman et al.· Brachytherapy· 0 citations
PBI using interstitial multi-catheter high dose-rate brachytherapy is effective and well-tolerated for selected early-stage breast cancer showing excellent long-term toxicity, cosmetic profiles, and outcomes.
Valeria Epifani, P. Anselmo, F. Arcidiacono et al.· Brachytherapy· 0 citations
DE-fsHDR is a safe and effective salvage treatment for IPR and GC score is a promising prognostic tool in patients undergoing salvage local therapy for IPR and warrants further study to guide treatment intensification.
A. Solanki, William Adams, James A. Proudfoot et al.· Journal of Clinical Oncology· 0 citations
High-dose hyperfractionated radiotherapy may be a feasible dose-escalated option for patients with LS-SCLC, with acceptable toxicity, with published data on the long-term outcomes of this specific regimen.
Yasuhito Hagiwara, Yuuki Kuroda, Kenji Takai et al.· Journal of Radiation Researc...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.